{"id":44561,"date":"2022-06-01T14:02:33","date_gmt":"2022-06-01T12:02:33","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-june\/"},"modified":"2022-06-01T14:02:33","modified_gmt":"2022-06-01T12:02:33","slug":"rallybio-to-present-at-upcoming-investor-conferences-in-june","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-june\/","title":{"rendered":"Rallybio to Present at Upcoming Investor Conferences in June"},"content":{"rendered":"<div>\n<p>NEW HAVEN, Conn.&#8211;(BUSINESS WIRE)&#8211;Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today announced its participation in the following upcoming investor conferences:\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220531005830\/en\/1407047\/5\/Press_Release_Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220531005830\/en\/1407047\/21\/Press_Release_Logo.jpg\"><\/a><\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<b>Jefferies Healthcare Conference <\/b>in New York, NY on Wednesday, June 8, 2022 at 10:30 a.m. ET.\n<\/li>\n<li>\n<b>JMP Securities Life Sciences Conference <\/b>in New York, NY on Wednesday, June 15, 2022 at 10:30 a.m. ET.\n<\/li>\n<\/ul>\n<p>\nA live webcast of each presentation will be accessible through the <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.rallybio.com%2Fevents-and-presentations%2Fevents&amp;esheet=52735546&amp;newsitemid=20220531005830&amp;lan=en-US&amp;anchor=Events+and+Presentations&amp;index=1&amp;md5=531d361cdddd1bc7276d8a4a79894a53\" rel=\"nofollow noopener\" shape=\"rect\">Events and Presentations<\/a> section of Rallybio\u2019s website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.rallybio.com&amp;esheet=52735546&amp;newsitemid=20220531005830&amp;lan=en-US&amp;anchor=www.rallybio.com&amp;index=2&amp;md5=a15fbe8b8c729f561f492e473659558c\" rel=\"nofollow noopener\" shape=\"rect\">www.rallybio.com<\/a>. A replay of the webcasts will be available for 30 days following each presentation.\n<\/p>\n<p>\n<b>About Rallybio<br \/>\n<br \/><\/b>Rallybio is a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases. Since its launch in January 2018, Rallybio has built a portfolio of promising product candidates, which are now in development to address rare diseases in the areas of hematology, immuno-inflammation, maternal fetal health, and metabolic disorders. The Company\u2019s mission is being advanced by a team of highly experienced biopharma industry leaders with extensive research, development, and rare disease expertise. Rallybio is headquartered in New Haven, Connecticut, with an additional facility at the University of Connecticut\u2019s Technology Incubation Program in Farmington, Connecticut. For more information, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.rallybio.com&amp;esheet=52735546&amp;newsitemid=20220531005830&amp;lan=en-US&amp;anchor=www.rallybio.com&amp;index=3&amp;md5=5a2ea640b7db2386bb0b4cc286ed7b87\" rel=\"nofollow noopener\" shape=\"rect\">www.rallybio.com<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Investor Contact<\/b><br \/>Steven Tuch<br \/>\n<br \/>Head of Corporate Development<br \/>\n<br \/>415-218-0697<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#x69;l&#116;&#x6f;:&#115;&#x74;&#x75;c&#104;&#x40;r&#97;&#x6c;&#x6c;y&#98;&#x69;o&#46;&#x63;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">s&#116;&#x75;&#x63;h&#64;&#x72;&#x61;l&#108;&#x79;&#x62;i&#111;&#x2e;&#x63;o&#109;<\/a>\n<\/p>\n<p>\nAmi Bavishi<br \/>\n<br \/>Head of Investor Relations and Communications<br \/>\n<br \/>609-477-4536<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#105;&#x6c;&#x74;&#x6f;&#x3a;a&#98;&#97;&#118;&#x69;&#x73;&#x68;i&#64;&#114;&#97;&#x6c;&#x6c;&#x79;bi&#111;&#46;&#x63;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x61;&#x62;&#x61;&#x76;&#105;&#115;&#104;&#105;&#64;ra&#x6c;&#x6c;&#x79;&#x62;&#x69;&#111;&#46;&#99;om<\/a>\n<\/p>\n<p>\nHannah Deresiewicz<br \/>\n<br \/>Stern Investor Relations, Inc.<br \/>\n<br \/>212-362-1200<br \/>\n<br \/><a target=\"_blank\" href=\"mai&#108;&#116;&#111;&#x3a;&#x68;&#x61;&#x6e;&#x6e;&#x61;h&#46;d&#101;&#114;&#101;&#115;&#x69;&#x65;&#x77;&#x69;&#x63;&#x7a;&#64;st&#101;&#114;&#110;&#x69;&#x72;&#x2e;&#x63;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#104;a&#x6e;n&#x61;&#104;&#x2e;&#100;&#x65;&#114;e&#x73;i&#x65;&#119;&#x69;&#99;&#x7a;&#64;&#x73;&#116;e&#x72;n&#x69;&#114;&#x2e;&#99;&#x6f;&#109;<\/a>\n<\/p>\n<p>\n<b>Media Contact<\/b><br \/>Tara DiMilia<br \/>\n<br \/>908-369-7168<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;:&#x54;a&#x72;a&#46;&#x64;&#105;&#x6d;&#105;&#x6c;&#105;&#x61;&#64;&#x74;m&#x73;t&#114;&#x61;&#116;&#x2e;&#99;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">Tara&#46;&#100;&#105;&#109;&#105;&#x6c;&#x69;&#x61;&#x40;&#x74;&#x6d;&#x73;trat&#46;&#99;&#111;&#109;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW HAVEN, Conn.&#8211;(BUSINESS WIRE)&#8211;Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today announced its participation in the following upcoming investor conferences: Jefferies Healthcare Conference in New York, NY on Wednesday, June 8, 2022 at 10:30 a.m. ET. JMP &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-june\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["entry","post","publish","author-business","post-44561","format-standard","category-industry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Rallybio to Present at Upcoming Investor Conferences in June - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-june\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rallybio to Present at Upcoming Investor Conferences in June - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"NEW HAVEN, Conn.&#8211;(BUSINESS WIRE)&#8211;Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today announced its participation in the following upcoming investor conferences: Jefferies Healthcare Conference in New York, NY on Wednesday, June 8, 2022 at 10:30 a.m. ET. JMP ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-june\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-01T12:02:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220531005830\/en\/1407047\/21\/Press_Release_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rallybio-to-present-at-upcoming-investor-conferences-in-june\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rallybio-to-present-at-upcoming-investor-conferences-in-june\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Rallybio to Present at Upcoming Investor Conferences in June\",\"datePublished\":\"2022-06-01T12:02:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rallybio-to-present-at-upcoming-investor-conferences-in-june\\\/\"},\"wordCount\":280,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rallybio-to-present-at-upcoming-investor-conferences-in-june\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220531005830\\\/en\\\/1407047\\\/21\\\/Press_Release_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rallybio-to-present-at-upcoming-investor-conferences-in-june\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rallybio-to-present-at-upcoming-investor-conferences-in-june\\\/\",\"name\":\"Rallybio to Present at Upcoming Investor Conferences in June - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rallybio-to-present-at-upcoming-investor-conferences-in-june\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rallybio-to-present-at-upcoming-investor-conferences-in-june\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220531005830\\\/en\\\/1407047\\\/21\\\/Press_Release_Logo.jpg\",\"datePublished\":\"2022-06-01T12:02:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rallybio-to-present-at-upcoming-investor-conferences-in-june\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rallybio-to-present-at-upcoming-investor-conferences-in-june\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rallybio-to-present-at-upcoming-investor-conferences-in-june\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220531005830\\\/en\\\/1407047\\\/21\\\/Press_Release_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220531005830\\\/en\\\/1407047\\\/21\\\/Press_Release_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rallybio-to-present-at-upcoming-investor-conferences-in-june\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rallybio to Present at Upcoming Investor Conferences in June\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rallybio to Present at Upcoming Investor Conferences in June - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-june\/","og_locale":"en_US","og_type":"article","og_title":"Rallybio to Present at Upcoming Investor Conferences in June - Pharma Trend","og_description":"NEW HAVEN, Conn.&#8211;(BUSINESS WIRE)&#8211;Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today announced its participation in the following upcoming investor conferences: Jefferies Healthcare Conference in New York, NY on Wednesday, June 8, 2022 at 10:30 a.m. ET. JMP ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-june\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-01T12:02:33+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220531005830\/en\/1407047\/21\/Press_Release_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-june\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-june\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Rallybio to Present at Upcoming Investor Conferences in June","datePublished":"2022-06-01T12:02:33+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-june\/"},"wordCount":280,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-june\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220531005830\/en\/1407047\/21\/Press_Release_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-june\/","url":"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-june\/","name":"Rallybio to Present at Upcoming Investor Conferences in June - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-june\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-june\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220531005830\/en\/1407047\/21\/Press_Release_Logo.jpg","datePublished":"2022-06-01T12:02:33+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-june\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-june\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-june\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220531005830\/en\/1407047\/21\/Press_Release_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220531005830\/en\/1407047\/21\/Press_Release_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-june\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Rallybio to Present at Upcoming Investor Conferences in June"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44561","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44561"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44561\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44561"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44561"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44561"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}